CIRM Funded Clinical Trials

A PHASE 1B STUDY EVALUATING THE SAFETY AND EFFICACY OF AN ALLOGENEIC CELL THERAPY IN SUBJECTS WITH CLEAR CELL RENAL CELL CARCINOMA (ccRCC)

Disease Area:
Investigator:
Institution:
CIRM Grant:
CLIN2-15343 (Active)
Award Value:
$15,000,000.00
Trial Sponsor:
Allogene Therapeutics
Trial Stage:
Phase 1
Trial Status:
Launching
Targeted Enrollment:
N/A

CIRM Clinical Trial Resources


Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox


Video on Stem Cell Trials


Other Resources

ISSCR Patient Website

ClinicalTrials.gov